445 related articles for article (PubMed ID: 35421449)
1. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
van Leeuwen LPM; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk F; van Gorp ECM; de Wilt F; Bogers S; Gommers L; Geers D; Bruns AHW; Leavis HL; van Haga JW; Lemkes BA; van der Veen A; de Kruijf-Bazen SFJ; van Paassen P; de Leeuw K; van de Ven AAJM; Verbeek-Menken PH; van Wengen A; Arend SM; Ruten-Budde AJ; van der Ent MW; van Hagen PM; Sanders RW; Grobben M; van der Straten K; Burger JA; Poniman M; Nierkens S; van Gils MJ; de Vries RD; Dalm VASH
J Allergy Clin Immunol; 2022 Jun; 149(6):1949-1957. PubMed ID: 35421449
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH;
Front Immunol; 2024; 15():1390022. PubMed ID: 38698851
[TBL] [Abstract][Full Text] [Related]
3. Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.
van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH;
J Clin Immunol; 2023 Aug; 43(6):1104-1117. PubMed ID: 37231290
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E
J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
Hagin D; Freund T; Navon M; Halperin T; Adir D; Marom R; Levi I; Benor S; Alcalay Y; Freund NT
J Allergy Clin Immunol; 2021 Sep; 148(3):739-749. PubMed ID: 34087242
[TBL] [Abstract][Full Text] [Related]
6. Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies.
Amodio D; Ruggiero A; Sgrulletti M; Pighi C; Cotugno N; Medri C; Morrocchi E; Colagrossi L; Russo C; Zaffina S; Di Matteo G; Cifaldi C; Di Cesare S; Rivalta B; Pacillo L; Santilli V; Giancotta C; Manno EC; Ciofi Degli Atti M; Raponi M; Rossi P; Finocchi A; Cancrini C; Perno CF; Moschese V; Palma P
Front Immunol; 2021; 12():727850. PubMed ID: 34671350
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y
J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D; Dziedzic R; Drynda A; Gradzikiewicz A; Jakieła B; Celińska-Löwenhoff M; Padjas A; Matyja-Bednarczyk A; Zaręba L; Bazan-Socha S
Front Immunol; 2023; 14():1275892. PubMed ID: 37901210
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.
Salinas AF; Mortari EP; Terreri S; Quintarelli C; Pulvirenti F; Di Cecca S; Guercio M; Milito C; Bonanni L; Auria S; Romaggioli L; Cusano G; Albano C; Zaffina S; Perno CF; Spadaro G; Locatelli F; Carsetti R; Quinti I
J Clin Immunol; 2021 Nov; 41(8):1709-1722. PubMed ID: 34669144
[TBL] [Abstract][Full Text] [Related]
10. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
Quinti I; Locatelli F; Carsetti R
Front Immunol; 2021; 12():815404. PubMed ID: 35126372
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine.
Gupta S; Agrawal S; Sandoval A; Su H; Tran M; Demirdag Y
J Clin Immunol; 2022 Jul; 42(5):914-922. PubMed ID: 35366743
[TBL] [Abstract][Full Text] [Related]
12. Antigen-Specific CD4
Sauerwein KMT; Geier CB; Stemberger RF; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
Front Immunol; 2022; 13():827048. PubMed ID: 35237272
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity.
Erra L; Uriarte I; Colado A; Paolini MV; Seminario G; Fernández JB; Tau L; Bernatowiez J; Moreira I; Vishnopolska S; Rumbo M; Cassarino C; Vijoditz G; López AL; Curciarello R; Rodríguez D; Rizzo G; Ferreyra M; Ferreyra Mufarregue LR; Badano MN; Pérez Millán MI; Quiroga MF; Baré P; Ibañez I; Pozner R; Borge M; Docena G; Bezrodnik L; Almejun MB
J Clin Immunol; 2023 Feb; 43(2):271-285. PubMed ID: 36251205
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
Milota T; Smetanova J; Skotnicova A; Rataj M; Lastovicka J; Zelena H; Parackova Z; Fejtkova M; Kanderova V; Fronkova E; Rejlova K; Sediva A; Kalina T
J Allergy Clin Immunol Pract; 2023 Jan; 11(1):306-314.e2. PubMed ID: 36379409
[TBL] [Abstract][Full Text] [Related]
15. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency.
Shin JJ; Par-Young J; Unlu S; McNamara A; Park HJ; Shin MS; Gee RJ; Doyle H; Afinogenova Y; Zidan E; Kwah J; Russo A; Mamula M; Hsu FI; Catanzaro J; Racke M; Bucala R; Wilen C; Kang I
J Clin Immunol; 2022 Aug; 42(6):1137-1150. PubMed ID: 35713752
[TBL] [Abstract][Full Text] [Related]
16. Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Göschl L; Mrak D; Grabmeier-Pfistershammer K; Stiasny K; Haslacher H; Schneider L; Deimel T; Kartnig F; Tobudic S; Aletaha D; Burgmann H; Bonelli M; Pickl WF; Förster-Waldl E; Scheinecker C; Vossen MG
Front Immunol; 2022; 13():974987. PubMed ID: 36189225
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity.
Delmonte OM; Bergerson JRE; Burbelo PD; Durkee-Shock JR; Dobbs K; Bosticardo M; Keller MD; McDermott DH; Rao VK; Dimitrova D; Quiros-Roldan E; Imberti L; Ferrè EMN; Schmitt M; Lafeer C; Pfister J; Shaw D; Draper D; Truong M; Ulrick J; DiMaggio T; Urban A; Holland SM; Lionakis MS; Cohen JI; Ricotta EE; Notarangelo LD; Freeman AF
J Allergy Clin Immunol; 2021 Nov; 148(5):1192-1197. PubMed ID: 34492260
[TBL] [Abstract][Full Text] [Related]
18. Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders.
Sauerwein KMT; Geier CB; Stemberger RF; Rossmanith R; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
J Allergy Clin Immunol; 2023 Apr; 151(4):922-925. PubMed ID: 36463978
[TBL] [Abstract][Full Text] [Related]
19. Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency.
Rosenthal JA; Papa MP; Sanz M; Nicholes S; Holmberg CS; Bosque A; Keswani A; Amdur R; Lynch RM; Soriano-Sarabia N; Ein D
Ann Allergy Asthma Immunol; 2023 Jun; 130(6):743-751.e3. PubMed ID: 36736722
[TBL] [Abstract][Full Text] [Related]
20. B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.
Pulvirenti F; Fernandez Salinas A; Milito C; Terreri S; Piano Mortari E; Quintarelli C; Di Cecca S; Lagnese G; Punziano A; Guercio M; Bonanni L; Auria S; Villani F; Albano C; Locatelli F; Spadaro G; Carsetti R; Quinti I
Cells; 2021 Oct; 10(11):. PubMed ID: 34831138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
